Delivery Order SPE2DB24D2010-SPE2DB24FZTK7
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order for $9,425.98 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical company Amerisourcebergen Corporation. The delivery order is for the supply of Eliquis 5 mg tablets and has a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation mentioned. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $47,006.39 contract is for the provision of Eliquis 5 mg tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $7,119.95 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of Eliquis 5 mg tablets and has a performance period through March 13, 2024. AmerisourceBergen Drug Corp is the prime contractor on this order, which was not set aside under any socioeconomic programs. Additionally, AmerisourceBergen Drug Corp holds an Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Eliquis 5 mg tablets. The total ceiling value of this contract is $22,619.00 with a period of performance through April 9, 2024. This delivery order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) issued by DLA to AmerisourceBergen Drug Corp as a single award vehicle to supply...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Eliquis 5 mg tablets. The $7,295.22 contract has a completion date of February 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA, which serves as the primary vehicle for the...
- The Defense Logistics Agency awarded a $12,104.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). The contract, designated as delivery order 4570270064, was competitively awarded without set-aside provisions and is scheduled for completion by December 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order is issued under...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $11,004.79 contract is for the delivery of Eliquis 5 mg tablets. This order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to supply pharmaceuticals and...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $37,550.10 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product Eliquis 5 mg tablets. This delivery order was issued under an existing indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA, which serves as the primary contract vehicle for the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,229.80 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by November 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work from its corporate office location. This delivery order is executed under...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order for $1,187.55 to supply 60 tablets of Eliquis 2.5 mg. This order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp by DLA, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB24FZTK7Delivery Order
The Defense Logistics Agency (DLA) awarded a $12,763.52 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Eliquis 5 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp to provide pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The IDC does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, and the contract will be performed at their facility in Conshohocken, Pennsylvania. This delivery order represents one of the firm fixed price task orders issued under the IDC to enable the supply of a wide range of medications and healthcare materials to the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 4/11/24 |